Inspire IVF Public Company Limited, or IVF, has acquired a 24% stake in Eternity Healthcare 369 Company Limited, or ETERNITY, and the two parties have begun discussing avenues for cooperation and are preparing cross-selling to connect their customer bases and expand joint business opportunities. Kesinee Kuldilok, Chief Executive Officer of IVF, said the partnership will reinforce the strengths of both sides, since ETERNITY specialises in men's health, particularly Urology, while IVF is strong in women's health and fertility treatment, covering egg freezing, IVF and ICSI, allowing the two to extend their health services to cover both women and men more comprehensively. The company has also expanded its services under Inspire IVF in the Wellness segment, which officially opened for service early last month on the G floor of the Ploenchit Center building, while the IVF centre is located on the 5th floor of the same building. The Wellness services cover vitamin infusions, blood tests, screening for 10 types of cancer, cell age testing and Hyperbaric Oxygen Therapy, targeting premium customers, who are currently mostly foreign clients, especially from the Middle East, whose per-capita spending is higher than that of Thai customers. For its second-half 2026 plan, the company will continue to market its IVF business, and in about two weeks it is preparing to market and hold roadshows in India in both B2B and B2C formats, bringing a team of doctors along to provide consultations, while in October it plans to travel to China to tap the B2B segment further, alongside driving the Wellness business and building synergies with ETERNITY.
IVF_INSPIRE IVFIVF acquired a 24% stake in Eternity Healthcare 369, an M&A/investment event that expands its healthcare ecosystem.
ETERNITY is selling a 24% stake to IVF, bringing in a strategic partner and investment.
